Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
O'Reilly Automotive
ORLY
|
+$450M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$321M |
| 3 |
Costco
COST
|
+$263M |
| 4 |
Ferrari
RACE
|
+$253M |
| 5 |
GE HealthCare
GEHC
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$998M |
| 2 |
Microsoft
MSFT
|
+$581M |
| 3 |
Apple
AAPL
|
+$553M |
| 4 |
Bank of America
BAC
|
+$301M |
| 5 |
UnitedHealth
UNH
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.47% |
| 2 | Healthcare | 13.56% |
| 3 | Financials | 11.46% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Industrials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Virgin Galactic
SPCE
$503M
| $3.6M | ﹤0.01% |
44,495
-1,038
| -2% | -$103K |
|
2477
Iovance Biotherapeutics
IOVA
$3.16B
| $3.59M | ﹤0.01% |
588,005
-11,848
| -2% | -$81.7K |
|
2478
Perimeter Solutions
PRM
$5.55B
| $3.59M | ﹤0.01% |
444,587
-5,481
| -1% | -$47.2K |
|
2479
Cytek Biosciences
CTKB
$610M
| $3.59M | ﹤0.01% |
390,541
-6,495
| -2% | -$69.9K |
|
2480
Republic Bancorp
RBCAA
$1.92B
| $3.59M | ﹤0.01% |
84,576
-3,958
| -4% | -$171K |
|
2481
First Trust Alternative Absolute Return Strategy ETF
FAAR
$196M
| $3.58M | ﹤0.01% |
120,529
-6,383
| -5% | -$191K |
|
2482
LegalZoom.com
LZ
$963M
| $3.57M | ﹤0.01% |
380,897
+483
| +0.1% | +$4.09K |
|
2483
DMC Global
BOOM
$155M
| $3.57M | ﹤0.01% |
162,602
-8,259
| -5% | -$189K |
|
|
ITOS
2484
DELISTED
iTeos Therapeutics
ITOS
| $3.57M | ﹤0.01% |
261,955
-12,418
| -5% | -$222K |
|
|
RNAM
2485
DELISTED
Avidity Biosciences
RNAM
| $3.56M | ﹤0.01% |
231,648
+35,555
| +18% | +$782K |
|
2486
Viridian Therapeutics
VRDN
$2.5B
| $3.55M | ﹤0.01% |
139,635
-12,918
| -8% | -$414K |
|
2487
First Trust Emerging Markets AlphaDEX Fund
FEM
$790M
| $3.55M | ﹤0.01% |
167,510
+615
| +0.4% | +$13.2K |
|
2488
W&T Offshore
WTI
$554M
| $3.54M | ﹤0.01% |
697,208
-50,155
| -7% | -$280K |
|
2489
MannKind Corp
MNKD
$1.24B
| $3.53M | ﹤0.01% |
861,052
-76,881
| -8% | -$371K |
|
2490
Rocket Pharmaceuticals
RCKT
$381M
| $3.53M | ﹤0.01% |
206,067
+16,599
| +9% | +$325K |
|
2491
Recursion Pharmaceuticals
RXRX
$1.69B
| $3.53M | ﹤0.01% |
529,157
+23,710
| +5% | +$188K |
|
2492
Lennar Class B
LEN.B
$20.6B
| $3.52M | ﹤0.01% |
41,491
+2,348
| +6% | +$187K |
|
|
FPI
2493
Farmland Partners
FPI
$433M
| $3.51M | ﹤0.01% |
328,127
+227
| +0.1% | +$2.66K |
|
2494
Petco
WOOF
$805M
| $3.5M | ﹤0.01% |
389,064
-952,385
| -71% | -$9.86M |
|
|
ACCD
2495
DELISTED
Accolade Inc
ACCD
| $3.5M | ﹤0.01% |
243,345
+3,791
| +2% | +$42.9K |
|
2496
indie Semiconductor
INDI
$995M
| $3.48M | ﹤0.01% |
329,871
+12,699
| +4% | +$113K |
|
2497
Vanda Pharmaceuticals
VNDA
$316M
| $3.47M | ﹤0.01% |
510,995
+5,402
| +1% | +$38K |
|
2498
Forrester Research
FORR
$217M
| $3.46M | ﹤0.01% |
106,884
-1,848
| -2% | -$64K |
|
2499
International Money Express
IMXI
$441M
| $3.44M | ﹤0.01% |
133,396
+582
| +0.4% | +$14.1K |
|
2500
Beyond Meat
BYND
$6.95B
| $3.42M | ﹤0.01% |
7,019
-128
| -2% | -$63.2K |
|
Similar funds
Bank of New York Mellon's Q1 2023 Portfolio in Review
As of Q1 2023, Bank of New York Mellon held 4,561 positions worth $457B, up 4.4% from $438B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q1 2023 filing shows 99 new, 1,204 increased, 2,632 reduced and 170 closed positions. Its largest new stake was GE HealthCare: 3,007,926 shares worth $247M. The largest sale was Johnson & Johnson, an estimated $998M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q1 2023 buy was GE HealthCare: 3,007,926 shares worth $247M.
- Bank of New York Mellon added most to O'Reilly Automotive in Q1 2023, an estimated $450M increase.
- Bank of New York Mellon's biggest Q1 2023 reduction was Johnson & Johnson, cutting an estimated $998M.
- Bank of New York Mellon fully exited STORE Capital Corporation in Q1 2023, selling an estimated $109M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $457B portfolio in Q1 2023.
- Bank of New York Mellon opened 99 new positions and closed 170 in Q1 2023.
- Bank of New York Mellon's portfolio value rose 4.4% quarter-over-quarter to $457B.
Based on Bank of New York Mellon's 13F filing for Q1 2023, filed 9 May 2023.